Research is the answer to one day making FA a treatable, manageable disease. Here, you'll discover the most recent strides in FA research and activities funded by FCF. Every quarter, we'll bring you updates on newly funded grants, ongoing projects, and significant milestones.
We are pleased to welcome longtime FARF supporter and FA parent Orion Marx to the Board of Directors. Following years of experience in the economic sector, Orion founded Atlas Financial, a firm which helps clients with financial, estate and business...
Announcements
Eugene, Ore. – The Fanconi Anemia Research Fund (FARF) recently received a grant from the M.J. Murdock Charitable Trust of Vancouver, Washington in the amount of $255,000 to expand FARF’s development program. This grant will allow FARF to generate greater...
Announcements
Joel Walker, an adult with FA, sadly passed away from complications of head and neck cancer in November 2016, at the age of 33. In honor of their son, Joel’s parents, Nigel and Ann Walker, created the Joel Walker Scientific...
Announcements
“Despite a rare, incurable disease, Amy Frohnmayer Winn ran joyfully through her limited time on earth, making the most of every mile—and every moment.” Click here to read the full article about Amy Winn in Runners World magazine, out 6/12/2017.
Stories
Click to read about FARF co-founder Lynn Frohnmayer’s mission to continue fighting Fanconi anemia.
Stories
